Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma
Condition: Asthma; Eosinophilic Intervention: Biological: Mepolizumab given SC 100mg every 4 weeks between Dec 2017 and Dec 2019 Sponsors: Medical University of Lodz; GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials